logo

Achaogen Inc. (AKAO)



Trade AKAO now with
  Date
  Headline
2/14/2018 8:09:52 AM Wedbush Is Lowering Achaogen Inc. (AKAO) FY18 Rev. Estimate To 11.0 M From 13.1 M
2/14/2018 8:09:17 AM Wedbush Is Increasing Achaogen Inc. (AKAO) Q4 18 Rev. Estimate To 4.3 M From 2.3 M
2/14/2018 8:09:00 AM Wedbush Is Increasing Achaogen Inc. (AKAO) Q3 18 Rev. Estimate To 3.1 M From 1.7 M
2/14/2018 8:08:47 AM Wedbush Is Cutting Achaogen Inc. (AKAO) Q2 18 Rev. Estimate To 1.8 M From 4.7 M
2/14/2018 8:08:35 AM Wedbush Is Cutting Achaogen Inc. (AKAO) Q1 18 Rev. Estimate To 1.8 M From 4.4 M
2/14/2018 8:07:51 AM Wedbush Is Increasing Achaogen Inc. (AKAO) FY18 Estimate To -2.92 From -4.02
2/14/2018 8:07:26 AM Wedbush Is Increasing Achaogen Inc. (AKAO) Q4 18 Estimate To -0.68 From -1.21
2/14/2018 8:07:11 AM Wedbush Is Increasing Achaogen Inc. (AKAO) Q3 18 Estimate To -0.68 From -1.12
2/14/2018 8:06:55 AM Wedbush Is Increasing Achaogen Inc. (AKAO) Q2 18 Estimate To -0.79 From -0.87
2/14/2018 8:06:39 AM Wedbush Is Raising Achaogen Inc. (AKAO) Q1 18 Estimate To -0.77 From -0.82
1/2/2018 8:15:46 AM Achaogen Announces Positive Top-line Results From Its Phase 1 Clinical Study Of C-Scape
1/2/2018 8:15:00 AM Achaogen Says FDA Accepts NDA With Priority Review For Plazomicin For Treatment Of Complicated Urinary Tract Infections
12/11/2017 4:02:49 PM Achaogen Appoints Blake Wise As CEO
11/24/2017 8:02:08 AM Achaogen Reports New Employment Inducement Grants
10/26/2017 8:13:23 AM Achaogen Submits Plazomicin NDA For Treatment Of Complicated Urinary Tract Infections And Bloodstream Infections